A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
Titel:
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
Auteur:
Annunziata, Christina M. Hernandez, Lidia Davis, R. Eric Zingone, Adriana Lamy, Laurence Lam, Lloyd T. Hurt, Elaine M. Shaffer, Arthur L. Kuehl, W. Michael Staudt, Louis M.